|
Dr. Daniel Delorme has almost 20 years experience in biotechnology and pharmaceutical companies. Prior to joining
Neurochem, he served between 2003 and 2005 as Vice President, Research and Development, at the Canadian biopharmaceutical
company Phagetech Inc. and from 1998 to 2003, Dr. Delorme was Vice President Medicinal Chemistry at Methylgene Inc.
From 1995 to 1998, Dr. Delorme served as Associate Director at AstraZeneca, Montreal, and prior to that as a Research
Fellow at Merck-Frosst. He is the co-inventor of 33 US patents and patent applications and the author of 42 scientific
papers. Dr. Delorme received his doctoral degree in Organic Chemistry from the Université de
Montréal.
|
|
